SCIENION
LIVE

Serial Number

76350957

Owner

Scienion AG

Attorney

Jeffrey H. Brown

Filing Date

Dec 20, 2001

Add to watchlist:

No watchlists yet
View on USPTO

SCIENION Trademark

Serial Number: 76350957 • Registration: 3152451

SCIENION is a trademark filed by Scienion AG on December 20, 2001. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Scienion AG

Volmerstr. 7a
12489 Berlin , DE

Entity Type: 03

Trademark Details

Filing Date

December 20, 2001

Registration Date

October 10, 2006

Published for Opposition

December 28, 2004

Goods & Services

Custom chemical synthesis for others, namely, synthesis of nucleic acids, peptides, and proteins for industrial and scientific purposes, synthesis of immobilized chemical compounds, arrays, and libraries of nucleic acids, peptides and proteins for industrial and scientific purposes; immobilization of chemical products for others, namely, immobilization of nucleic acids, peptides, and proteins for industrial and scientific purposes, immobilization of arrays and libraries of nucleic acids, peptides and proteins for industrial and scientific purposes; custom manufacture, spotting, and design of biochips for others

Scientific measure and controlling apparatus and instruments; support materials, more particularly membranes and glass; scientific instruments and devices comprising support materials, more particularly membranes and glass, comprising chemical products for industrial and scientific purposes, more particularly nucleic acids, peptides and proteins, comprising immobilized chemical compounds, comprising libraries of chemical compounds for industrial and scientific purposes, more particularly immobilized chemical compounds for industrial and scientific purposes, comprising arrays of chemical compounds, more particularly of nucleic acids, peptides and proteins, comprising arrays of libraries of chemical compounds, more particularly libraries of chemical compounds arranged on a support, comprising compounds produced by using or by means of immobilized chemical compounds, libraries of chemical compounds or arrays of chemical compounds, more particularly such chemical compounds which are immobilized on a support, comprising chemical compounds for industrial and scientific purposes manufactured by using or by means of chemical products for industrial and scientific purposes, more particularly nucleic acids, peptides and proteins; computer software and programs, more particularly computer programs for synthesis and/or immobilization of chemical products for industrial and scientific purposes, more particularly nucleic acids, peptides and proteins, of immobilized chemical compounds, of arrays of libraries of chemical compounds, more particularly arrays of chemical compounds arranged on a support, of compounds manufactured with the aid of immobilized chemical compounds, libraries of chemical compounds or arrays of chemical compounds, more particularly such compounds which are immobilized on a support; computer software (saved), computer programs, more particularly computer programs for analysis of patterns of surfaces, more particularly of support materials like membranes and glass, more particularly such supports comprising chemical products for industrial and scientific purposes, more particularly nucleic acids, peptides and proteins, for analysis of immobilized chemical compounds, for analysis of chemical compounds for industrial and scientific purposes, for analysis of arrays of chemical compounds, more particularly of nucleic acids, peptides and proteins, for analysis of arrays of libraries of chemical compounds, more particularly libraries of chemical compounds arranged on a support, for analysis of compounds manufactured with the aid of immobilized chemical compounds, libraries of chemical compounds or arrays of chemical compounds, more particularly such compounds which are immobilized on a support; programs, more particularly computer programs, for screening of compounds such as nucleic acids, peptides and proteins; software for picture evaluation; and software for data evaluation; apparatus and apparatus for analysis for use in synthesis and/or immobilization of chemical products for industrial and scientific purposes, for production and analysis of patterns of surfaces and for screening of compounds such as nucleic acids, peptides and proteins, more particularly such apparatus and apparatus for analysis with integrated data analysis; diagnostic apparatus and analysis apparatus for synthesis and/or immobilization of chemical products for industrial and scientific purposes, for production and analysis of patterns of/on surfaces and for screening of compounds such as nucleic acids, peptides and proteins, more particularly such apparatus and analysis apparatus with integrated data analysis; chambers, more particularly chambers for hybridization; spotting apparatus

[ Pharmaceutical and veterinary products, namely, antiseptics, slimming, appetite suppressants, pharmaceuticals for acidosis therapeutics, analeptic and antihypoxaemics; analgesics and antirheumatic drags, pharmaceuticals functioning as antihelmintics, antiallergics, antianemia drugs, antiarrhythmics, antibiotics and antiinfectives, antidementics, nootropics, antidiabetics, antidotes for the treatment of poisoning, antiemetics and antivertiginosics, antiepileptics, antihemorrhagics, antifibrinolyrics, hemostatics, antihypertonics, antihypoglycemics, antihypotonica, anlicoagulauts, antimycotics, pharmaceuticals functioning as antiparasitics, antiphiogistics, antitussives, expectorants for use in atherosclerosis, balneotherapeutics and pharmaceuticals for thermal therapy, pharmaceuticals functioning as beta receptor blocking agents, pharmaceuticals for calcium channel blocking and inhibiting of the renin angiotensin system, pharmaceuticals functioning as broncholytics, antiasthmetics cholagoguegics and for use in biliary tract therapeutics; pharmaceuticals functioning as cholinergics, corticoids, dermatics; all purpose disirifectants and antiseptics; pharmaceuticals functioning as dietetic agents and in alimentary therapeutics; diagnostic preparations functioning as diuretics, as agents for favoring blood flow, as withdrawal agents, as fibrinolytics, to treat gout, the flu and catarrhal fever; pharmaceuticals for the treatment of gynecological illnesses, namely, menstrual cramps, hemorrhoids, hepatitis; pharmaceuticals functioning as hypnotics and sedatives; pharmaceuticals to treat cardiac ailments; pharmaceuticals for use in caries and parodontosis; dental preparations, namely, dental abrasives; laxatives, pharmaceuticals functioning as antilipaemics, local anesthetics, neural therapeutics, gastro-ititestinal preparations, pharmaceuticals to treat migraines; pharmaceutical preparations for use in mouth and pharyngeal therapeutics; pharmaceuticals for use as muscle relaxants; pharmaceuticals for the treatment of addiction to narcotics; pharmaceuticals for use in neuropathology; ophthalmic pharmaceuticals for treating blindness, conjunctivitis, cataract, glaucoma, retinal detachment, stye, chalazion, dacryoadenitis, corneal clouding, keratitis, gasserian ganglionitis, vitreous opacity, amaurosis, retinopathy, central retinal artery occlusion, retinoblastoma, melanoma, optic neuritis, optic nerve atrophy; pharmaceuticals for use in osteoporosis and calcium metabolism modification; pharmaceuticals for the treatment of Parkinson's Disease and disturbances of the extrapyramidal system; pharmaceuticals for psychotropic, rhinologic and sinositic purposes; pharmaceuticals functioning as roborants and tonics; pharmaceuticals for use in thyroidal therapeutics; pharmaceuticals functioning as spasmolytics and inhibitors of thrombocyte aggregation; pharmaceuticals for the treatment of tuberculosis; pharmaceuticals functioning as alternants, urologics and venous agents; vitamins; pharmaceuticals for use as cytostatics and antineoplastic agents; homeopathic remedies for use in the treatment of salmonellosis, paratuberculosis and cancer; veterinary preparations for use in the treatment of diseases equivalent to salnionellosis, paratubeculosis and cancer; pharmaceutical and veterinary products, namely, antiseptics, slimming, appetite suppressants, pharmaceuticals for acidosis therapeutics, analeptic and antihypoxaemics; analgesics and antirhsuinatic drugs, pharmaceuticals functioning as antihelmintics, antiallergics, antianemia drugs, antiarrhythmics, antibiotics and antlinfectives, antidementics, nootropics, antidiabetics, antidotes for the treatment of poisoning, antiemetics and antivertiginosics; antiepileptics, antihermorrhagics, antifibrinolyrics, hemostatic; antihypertonics, antihypoglycomics, antihypotonica, anticoagulant; antimycotics, pharmaceuticals functioning as antiparasitics, antiphiogistics, antitussives, expectorants for use in atherosclerosis, balneotherapeutics and pharmaceuticals for thermal therapy, pharmaceuticals functioning as beta receptor blocking agents, pharmaceuticals for calcium channel blocking and inhibiting of the renin angiotensinir system, pharmaceuticals functioning as broncholytics, antiastlimetics cholagoguegics and for use in biliary tract therapeutics; pharmaceuticals functioning as cholinergics, corticoids, dermatics; all purpose disinfeetants and antiseptics; pharmaceuticals functioning as dietetic agents and in alimentary therapeutics; diagnostic preparations functioning as diuretics, as agents for favoring blood flow, as withdrawal agents, as fibrinolytics, to treat gout, the flu and catarrhal fever; pharmaceuticals for the treatment of gynecological illnesses, namely, menstrual cramps, hemorrhoids, hepatitis; pharmaceuticals functioning as hypnotics and sedatives; pharmaceuticals to treat cardiac ailments; pharmaceuticals for use in caries and parodontosis; dental preparations, namely, dental abrasives; laxatives, pharmaceuticals functioning as antilipaemics, local anesthetics, neural therapeutics, gastro- intestinal preparations, pharmaceuticals to treat migraines; pharmaceutical preparations for use in mouth and pharyngeal therapeutics; pharmaceuticals for use as muscle relaxants; pharmaceuticals for the treatment of addiction to narcotics; pharmaceuticals for use in neuropathology; ophthalmic pharmaceuticals for treating blindness, conjunctivitis, cataract, glaucoma, retinal detachment, stye, chalazion, daoryoadenitis, corneal clouding, keratitis, gasserian ganglionitis, vitreous opacity, amaurosis, retinopathy, central retinal artery occlusion, retinoblastoma, melanoma, optic neuritis, optic nerve atrophy; pharmaceuticals for use in osteoporosis and calcium metabolism modification; pharmaceuticals for the treatment of Parkinson's Disease and disturbances of the extrapyramidal system; pharmaceuticals for psychotropic, rhinologic and sinositic purposes; pharmaceuticals functioning as roborants and tonics; pharmaceuticals for use in thyroidal therapeutics; pharmaceuticals functioning as spasmolytics and inhibitors of thrombocyte aggregation; pharmaceuticals for the treatment of tuberculosis; pharmaceuticals functioning as alternants, urologica and venous agents; vitamins; pharmaceuticals for use as cytostatics and antineoplastic agents; homeopathic remedies far use in the treatment of salmonellosis, paratubereulosis and cancer; arrays of libraries of chemical compounds arranged on a support for clinical or medical laboratory use; chemical compounds arranged on a support for clinical or medical laboratory use; nutraceuticals for use in dietary supplements ]

Chemical products for industrial and scientific purposes, namely, nucloic acids, peptides and proteins for scientific and research use in the fields of phannacology, foodstuffs, plant protection, cosmetics, diagnostics and biochemical and medical research; libraries of immobilized chemical compounds for scientific and research use in the fields of pharmacology, foodstuffs, plant protection, cosmetics, diagnostics and biochemical and medical research; arrays of chemical compounds, namely, nucleic acids, peptides and proteins for scientific and research use in the fields of pharmacology, foodstuffs, plant protection, cosmetics, diagnostics and biochemical and medical research; arrays of libraries of chemical compounds arranged on a support for scientific and research use in the fields of pharmacology, foodstuffs, plant protection, cosmetics, diagnostics and biochemical and medical research; chemical compounds produced by using immobilized chemical compounds, libraries of chemical compounds and arrays of chemical compounds, namely, such compounds which are immobilized on a support for scientific and research use in the fields of pharmacology, foodstuffs, plant protection, cosmetics, diagnostics and biochemical and medical research

Product research and development in the fields in the fields of biology, biochemistry, chemistry, medicine, veterinary medicine, pharmacology, genetics, cytogenetics, molecular biology, and biotechnology, namely, products used in the synthesis and immobilization of chemical products for industrial and scientific purposes, products research and development in the field of synthesis and immobilization of arrays and arrays of libraries of chemical compounds arranged on a support; scientific research, namely, screening for chemical interaction partners; product research and development in the field of chemical screening for interaction partners; development of new diagnostic technology for others in the fields of biology, biochemistry, chemistry, medicine, veterinary medicine, pharmacology, genetics, cytogenetics, molecular biology, and biotechnology; screening and development of arrays and libraries of arrays of immobilized chemical compounds arranged on a support for industrial and scientific purposes; development of computer software for use in screening and development of arrays and libraries of arrays of immobilized chemical compounds arranged on a support for industrial and scientific purposes; development of data processing software for use in product research and screening; database development and providing an on-line database in the field of product research and development in the fields of biology, biochemistry, chemistry, medicine, veterinary medicine, pharmacology, genetics, cytogenetics, molecular biology, and biotechnology

Filing History

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Oct 10, 2025 REM2
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 5, 2017 TCCA
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Jan 13, 2017 NA89
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Jan 13, 2017 RNL1
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Jan 13, 2017 89AG
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Jan 10, 2017 EROP
POST REGISTRATION ACTION MAILED - SEC. 8 & 9
Sep 7, 2016 PR89
TEAS SECTION 8 & 9 RECEIVED
Sep 6, 2016 E89R
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Oct 10, 2015 REM2
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Mar 15, 2013 NA85
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Mar 15, 2013 C15P
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Mar 15, 2013 APRE
REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Mar 1, 2013 815F
TEAS SECTION 8 & 15 RECEIVED
Mar 1, 2013 E815
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 22, 2011 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 3, 2010 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 3, 2010 REAP
REVIEW OF CORRESPONDENCE COMPLETE
Oct 24, 2007 CORV
PAPER RECEIVED
Oct 19, 2007 MAIL
REGISTERED-PRINCIPAL REGISTER
Oct 10, 2006 R.PR
1(B) BASIS DELETED; PROCEED TO REGISTRATION
Aug 25, 2006 DP1B
NOTICE OF ALLOWANCE CANCELLED
Aug 25, 2006 IUCN
PAPER RECEIVED
Aug 8, 2006 MAIL
SOU EXTENSION 2 GRANTED
Mar 6, 2006 EX2G
SOU EXTENSION 2 FILED
Mar 6, 2006 EXT2
SOU TEAS EXTENSION RECEIVED
Mar 6, 2006 EEXT
UNDELIVERABLE MAIL - NO ACTION TAKEN
Dec 21, 2005 UNDN
PAPER RECEIVED
Dec 6, 2005 MAIL
SOU EXTENSION 1 GRANTED
Dec 1, 2005 EX1G
PETITION TO REVIVE-GRANTED
Nov 16, 2005 PETG
PETITION TO REVIVE-RECEIVED
Oct 4, 2005 PETR
PAPER RECEIVED
Oct 4, 2005 MAIL
SOU EXTENSION 1 FILED
Sep 22, 2005 EXT1
NOA MAILED - SOU REQUIRED FROM APPLICANT
Mar 22, 2005 NOAM
PUBLISHED FOR OPPOSITION
Dec 28, 2004 PUBO
NOTICE OF PUBLICATION
Dec 8, 2004 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Oct 19, 2004 PREV
ASSIGNED TO LIE
Oct 8, 2004 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 6, 2004 CNSA
PAPER RECEIVED
Aug 3, 2004 MAIL
AMENDMENT FROM APPLICANT ENTERED
Jun 18, 2004 ACEC
UNRESPONSIVE/DUPLICATE PAPER RECEIVED
Jun 18, 2004 UNPR
PAPER RECEIVED
Jun 18, 2004 MAIL
FINAL REFUSAL MAILED
Feb 4, 2004 CNFR
CASE FILE IN TICRS
Dec 18, 2003 CFIT
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 24, 2003 CRFA
PAPER RECEIVED
Nov 24, 2003 MAIL
INQUIRY AS TO SUSPENSION MAILED
May 22, 2003 CNSI
LETTER OF SUSPENSION MAILED
Nov 7, 2002 CNSL
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 27, 2002 CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 23, 2002 CRFA
NON-FINAL ACTION MAILED
Mar 28, 2002 CNRT
ASSIGNED TO EXAMINER
Mar 8, 2002 DOCK